Zenta Tsuchihashi

Company: Daiichi Sankyo, Inc.

Job title: Senior Director - Translational Science & Oncology

Seminars:

Investigating the Possibility of Biomarkers in Order to Correctly Prescribe ADCs Dependent on Individual Patient Response to Toxicities 12:15 pm

Discovering the possibility of biomarkers to understand amount/application of ADC dosing dependent on patient screening results Looking at patient-dependent liabilities to toxicities to decide on whether the prescription of an ADC would be beneficial. Identifying which biomarkers are indicative of higher toxicity levelsRead more

day: Conference Day 1